Difference between revisions of "CTSC:TTIC.020210"

From NAMIC Wiki
Jump to: navigation, search
(Created page with ''''Agenda''' # Consultations: Imaging 119: We are trying to develop vectors for brain tumor gene therapy with MRI properties. For this reason we thought to use petides with CEST…')
 
Line 1: Line 1:
 +
Back to [[Collaboration:Harvard_CTSC|Collaboration:Harvard_CTSC]]
 +
<br>
 +
 
'''Agenda'''
 
'''Agenda'''
  
Line 5: Line 8:
 
# Education program
 
# Education program
 
# Imaging RFA for junior investigators
 
# Imaging RFA for junior investigators
 +
 +
<br>
 +
 +
== Harvard Translational Imaging Consortium Meeting Minutes February 2010 ==
 +
 +
In attendance:
 +
 +
* Valerie Humblet
 +
* Annick Van den Abbeele
 +
* Randy Gollub
 +
* Bob Lenkinski
 +
* Clare Tempany
 +
* Ron Kikinis
 +
* Simon Warfield
 +
* Gordon Williams
 +
* Charles Guttmann

Revision as of 20:27, 2 February 2010

Home < CTSC:TTIC.020210

Back to Collaboration:Harvard_CTSC

Agenda

  1. Consultations: Imaging 119: We are trying to develop vectors for brain tumor gene therapy with MRI properties. For this reason we thought to use petides with CEST contrast properties and engineer them into our viral vectors. We are a team that includes a cancer biologist, a virologist, neurosurgeon, neuro-oncologist, and a physicist with strong CETS MRI experience. To complete our work we need a protein chemist for the design of optimal peptides that can be used for our purposes.
  2. Vignettes about the use of of imaging in CTSA-related projects
  3. Education program
  4. Imaging RFA for junior investigators


Harvard Translational Imaging Consortium Meeting Minutes February 2010

In attendance:

  • Valerie Humblet
  • Annick Van den Abbeele
  • Randy Gollub
  • Bob Lenkinski
  • Clare Tempany
  • Ron Kikinis
  • Simon Warfield
  • Gordon Williams
  • Charles Guttmann